Sanofi Confirmed as First Tenant of Translational Research Institute’s ENTRI Biomanufacturing Hub

Brisbane biomanufacturing hub signs its first tenant

The Translational Research Institute (TRI) has announced that global healthcare company Sanofi will be the first tenant in its new facility, ENTRI, which is nearing completion in Brisbane. Sanofi’s presence at ENTRI is part of an expansion for the Translational Science Hub, which connects researchers with the company’s scientists in France and the US. The TRI says Sanofi’s presence will help stimulate the local biomedical sector through its expe…

Sanofi Joins TRI’s ENTRI Biomanufacturing Hub

Image: Grispb/stock.adobe.comGlobal healthcare company Sanofi will become the first tenant of the Translational Research Institute’s (TRI) new ENTRI biomanufacturing facility in Brisbane, marking a significant milestone for Queensland’s expanding biomedical sector. The tenancy comes as ENTRI nears completion and forms part of a broader expansion of the Translational Science Hub – a partnership linking Queensland researchers with Sanofi scientist…

Sanofi confirmed as first tenant of Translational Research Institute’s ENTRI biomanufacturing hub

Global healthcare company Sanofi will become the first tenant of the Translational Research Institute’s (TRI) new ENTRI biomanufacturing facility in Brisbane, the Institute announced, marking what it described as a significant milestone for Queensland’s biomedical sector. In a news release, TRI said Sanofi’s tenancy forms part of a broader expansion of the Translational Science Hub, which links local researchers with the company’s international …